Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.64 USD | -1.39% | +0.22% | +8.94% |
May. 15 | VBI Vaccines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Earnings Flash (VBIV) VBI VACCINES Reports Q1 Revenue $1.2M | MT |
Financials (USD)
Sales 2024 * | 12.84M | Sales 2025 * | 34.12M | Capitalization | 18.61M |
---|---|---|---|---|---|
Net income 2024 * | -42M | Net income 2025 * | -14M | EV / Sales 2024 * | 1.45 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-0.53
x | P/E ratio 2025 * |
-2.32
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
1 day | -1.39% | ||
1 week | +0.22% | ||
Current month | +12.08% | ||
1 month | +11.50% | ||
3 months | +13.27% | ||
6 months | +8.29% | ||
Current year | +8.94% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 15-07-08 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-05-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 23-04-23 |
Steven Gillis
CHM | Chairman | 71 | 04-12-31 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 16-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +10.17% | - | |
0.00% | 17 M€ | +5.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.64 | -1.39% | 53,821 |
24-05-24 | 0.649 | +3.02% | 50,734 |
24-05-23 | 0.63 | -1.56% | 102,581 |
24-05-22 | 0.64 | -1.45% | 49,384 |
24-05-21 | 0.6494 | +1.69% | 57,292 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.94% | 18.61M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- VBIV Stock